Little is known about the treatment of multidrug-resistant tuberculosis (MDR-TB) in HIV-co-infected adolescents. This study aimed to present the intermediate outcomes of HIV-infected adolescents aged 10–19 years receiving second-line anti-TB treatment in a Médecins Sans Frontières (MSF) project in Mumbai, India.
Original Source [2]
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/poor-outcomes-cohort-hiv-infected-adolescents-undergoing-treatment-multidrug
[2] http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0068869
[3] http://admin.indiaenvironmentportal.org.in/category/author/petros-isaakidis
[4] http://admin.indiaenvironmentportal.org.in/category/author/roma-paryani
[5] http://admin.indiaenvironmentportal.org.in/category/author/samsuddin-khan-et-al
[6] http://admin.indiaenvironmentportal.org.in/category/journal/plos-one
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/tuberculosis
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/aids
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health-care
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/mumbai
[11] http://admin.indiaenvironmentportal.org.in/category/thesaurus/india
